3rd Cell Therapy Analytical Development Summit Europe

September 3 - 5, 2024 - GB

Hanson Wade

Phone:+44 (0)20 3141 8700

Faced with many regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA. Join analytical development and quality control experts from industry-leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson and Johnson, GSK, MHRA, to tackle challenges from product characterisation to method validation and release preparation. Seize the chance this September to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward! Time: 9:00 AM - 4:00 PM

More Information